TAPIMIO 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Neuraxpharm Spain S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: fea948e00f47893f
Drug Cima Aemps Name: TAPIMIO 250 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number: 88226
Holder Company Name: Neuraxpharm Spain S.L.
Marketing Company Name: Neuraxpharm Spain S.L.
Authorization Date: 2022-11-22
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 250 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized: Yes
Company Name: Neuraxpharm Spain S.L.

TAPENTADOL FOSFATO

382,84 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 22, 2022

Approval ID

fea948e00f47893f

Type

Standard